000			01246 a2200349 4500
005			20250513010806.0
264		0	_c19821203
008			198212s 0 0 eng d
022			_a0361-5960
040			_aNLM _beng _cNLM
100	1		_aBruckner, H W
245	0	0	_aStudies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report. _h[electronic resource]
260			_bCancer treatment reports _cSep 1982
300			_a1713-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGastrointestinal Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMyeloproliferative Disorders _xchemically induced
650	0	4	_aPrognosis
650	0	4	_aRandom Allocation
650	0	4	_aRazoxane _xtherapeutic use
650	0	4	_aTriazines _xadverse effects
700	1		_aLokich, J J
700	1		_aStablein, D M
773	0		_tCancer treatment reports _gvol. 66 _gno. 9 _gp. 1713-7
999			_c7115962 _d7115962